0001553878-15-000029.txt : 20151113
0001553878-15-000029.hdr.sgml : 20151113
20151113163645
ACCESSION NUMBER: 0001553878-15-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151111
FILED AS OF DATE: 20151113
DATE AS OF CHANGE: 20151113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STARR KEVIN P
CENTRAL INDEX KEY: 0001192603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 151229638
MAIL ADDRESS:
STREET 1: 75 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-11-11
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001192603
STARR KEVIN P
300 THIRD STREET
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2015-11-11
4
M
0
25000.0
9.3
A
25000
D
Common Stock
2015-11-11
4
M
0
12500.0
11.33
A
37500
D
Common Stock
2015-11-11
4
S
0
2274.0
105.3117
D
35226
D
Common Stock
2015-11-11
4
S
0
4027.0
106.4611
D
31199
D
Common Stock
2015-11-11
4
S
0
12606.0
107.3901
D
18593
D
Common Stock
2015-11-11
4
S
0
15499.0
108.2258
D
3094
D
Common Stock
2015-11-11
4
S
0
3094.0
109.1417
D
0
D
Common Stock
2015-11-12
4
M
0
12500.0
11.33
A
12500
D
Common Stock
2015-11-12
4
M
0
25000.0
15.82
A
37500
D
Common Stock
2015-11-12
4
S
0
35400.0
100.0135
D
2100
D
Common Stock
2015-11-12
4
S
0
1200.0
101.5825
D
900
D
Common Stock
2015-11-12
4
S
0
900.0
103.0089
D
0
D
Stock Option (right to buy)
11.33
2015-11-11
4
M
0
12500.0
0.0
D
2013-06-21
2022-06-21
Common Stock
12500
12500
D
Stock Option (right to buy)
11.33
2015-11-12
4
M
0
12500.0
0.0
D
2013-06-21
2022-06-21
Common Stock
12500
0
D
Stock Option (right to buy)
15.82
2015-11-12
4
M
0
25000.0
0.0
D
2011-06-02
2020-06-02
Common Stock
25000
0
D
Stock Option (right to buy)
9.3
2015-11-11
4
M
0
25000.0
0.0
D
2012-06-09
2021-06-09
Common Stock
25000
0
D
The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2015.
Sale prices ranged from $104.85 to $105.70.
Sale prices ranged from $105.86 to $106.85.
Sale prices ranged from $106.88 to $107.875.
Sale prices ranged from $107.88 to $108.81.
Sale prices ranged from $108.92 to $109.62.
Sale prices ranged from $100.00 to $100.85.
Sale prices ranged from $101.02 to $101.92.
Sale prices ranged from $102.67 to $103.44.
The option vested, in full, on the first anniversary of the Grant Date.
By: /s/ Michael P. Mason, Attorney-In-Fact For: Kevin P. Starr
2015-11-13